WealthSource Partners’s Trinity Biotech TRIB Stock Holding History

WealthSource Partners’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$13K	Hold	201	–	–	﹤0.01%	499
2023 Q3	$22.2K	Hold	201	–	–	﹤0.01%	483
2023 Q2	$28.7K	Hold	201	–	–	﹤0.01%	486
2023 Q1	$28.4K	Hold	201	–	–	﹤0.01%	483
2022 Q4	$29.9K	Hold	201	–	–	﹤0.01%	475
2022 Q3	$32K	Hold	201	–	–	﹤0.01%	480
2022 Q2	$37K	Hold	201	–	–	﹤0.01%	504
2022 Q1	$32K	Hold	201	–	–	﹤0.01%	567
2021 Q4	$43K	Hold	201	–	–	﹤0.01%	546
2021 Q3	$65K	Buy	201 +1	+0.5%	+$352	0.01%	502
2021 Q2	$88K	Hold	200	–	–	0.01%	454
2021 Q1	$113K	Hold	200	–	–	0.01%	424
2020 Q4	$114K	Buy	200 +14	+8%	+$6.95K	0.01%	371
2020 Q3	$56K	Buy	186 +53	+40%	+$18.4K	0.01%	352
2020 Q2	$44K	Buy	+133	New	+$30.4K	0.01%	332

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return

WealthSource Partners's TRIB Position: Q4 2023 in Review

WealthSource Partners held its Trinity Biotech (TRIB) position steady in Q4 2023 at 201 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

WealthSource Partners first reported a position in TRIB in Q2 2020 and has held it in 15 quarters since. The position peaked at $114K in Q4 2020. 24 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

WealthSource Partners held 201 shares of Trinity Biotech worth $13K as of Q4 2023.
WealthSource Partners left its Trinity Biotech share count unchanged in Q4 2023.
Trinity Biotech made up ﹤0.01% of WealthSource Partners's portfolio in Q4 2023, its #499 holding.
WealthSource Partners first reported a position in Trinity Biotech in Q2 2020 and has held it in 15 quarters since.
WealthSource Partners's Trinity Biotech position peaked at $114K in Q4 2020.
24 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.